Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is a Phase I, single centre, randomised, double-blind, placebo-controlled, parallel group study to assess the safety, tolerability and pharmacokinetics of AZD2423 following single ascending dose administration to healthy Japanese subjects.
Critère d'inclusion
- healthy volunteer